XTL Biopharmaceuticals Ltd.
$1.96
+0.05 (+2.62%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -18.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -41.8%
Own XTLB?
See how XTLB contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.